ScienceDex / Researcher record
Hall, Matthew
- National Center for Advancing Translational Sciences (no department on record)
From the FY2017 NIH awards this investigator leads as contact PI. The department is the award's.
- Rising Star
- Sustained Excellence
- Top 10% Funded
NIH Funding · FY2017
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2015 | $380,000 | 16 | #20,348 |
| 2016 | $1,060,972 | 21 | #6,416 |
| 2017 | $2,652,864 | 24 | #1,660 |
| 2018 | $4,529,663 | 32 | #649 |
| 2019 | $6,391,005 | 24 | #424 |
| 2021 | $7,877,703 | 15 | #354 |
| 2022 | $91,565,549 | 19 | #8 |
| 2023 | $44,171,278 | 15 | #23 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY201516 records
- FY201621 records
- FY2017 · selected24 records
- FY201832 records
- FY201924 records
- FY202115 records
- FY202219 records
- FY202315 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2015 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2017 award records by amount
NIH award records listing Hall, Matthew as a PI. Multi-PI records show the full award amount for context.
- 1ZIATR000236-03ZIAContact PIIdentification of Inhibitors of Phosphoglycerate Dehydrogenase (PHGDH)$251.6Kaward amount
- 1ZIATR000264-02ZIAContact PIDevelopment of small molecule modulators of WDR5/MLL1 protein-protein binding (Chemical Biology Consortium/NCI Experimental Therapeutics Collaboration)$251.6Kaward amount
- 1ZIATR000284-01ZIAContact PIPET radiolabeling of mutant IDH1 inhibitors$251.6Kaward amount
- 1ZIATR000199-03ZIAContact PIBRD4 Inhibitors as Potential Therapeutics for Oncology$251.6Kaward amount
- 1ZIATR000262-02ZIAContact PIAdvanced development of human mutant IDH1 inhibitors (Chemical Biology Consortium/NCI Experimental Therapeutics Collaboration)$251.6Kaward amount
- 1ZIATR000144-03ZIAContact PIqHTS to Identify Inhibitors of the Arf GTPase-activating Protein ASAP1$135.7Kaward amount
- 1ZIATR000131-02ZIAContact PIqHTS to Identify Substrates of P-glycoprotein (P-gp) and Collateral Sensitivity agents of P-gp-expressing Cancer Cells$135.7Kaward amount
- 1ZIATR000198-03ZIAContact PIAdvanced Development of Inhibitors of human Lactate Dehydrogenase A (LDHA) as Anticancer Agents (Chemical Biology Consortium/NCI Experimental Therapeutics Collaboration)$135.7Kaward amount
- 1ZIATR000291-01ZIAContact PIIdentification of inhibitors of Zika Protease (NS2B-NS3)$135.7Kaward amount
- 1ZIATR000283-01ZIAContact PIqHTS to Identify Compounds against Merkel Cell Carcinoma (MCC)$135.7Kaward amount
+14 more grants not shown.
Award organization
Organizations that administered FY2017 awards listing Hall, Matthew as a PI.
FY2017 award administered by National Center for Advancing Translational Sciences ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2015First NIH AwardNational Center for Advancing Translational Sciences
- 2016$500K Cumulative Funding
- 2016$1M Cumulative Funding
- 2016Entered Top 50% NationallyRanked #6416
- 2017$2M Cumulative Funding
- 2017Entered Top 25% NationallyRanked #1660
- 2017Entered Top 10% NationallyRanked #1660
- 2018$5M Cumulative Funding
- 2018Entered Top 5% NationallyRanked #649
- 2019$10M Cumulative Funding
- 2022$25M Cumulative Funding
- 2022$50M Cumulative Funding
- 2022$100M Cumulative Funding
- 2022Entered Top 1% NationallyRanked #8